Russell Investments Group, Ltd. Mersana Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 10,765 shares of MRSN stock, worth $27,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,765

Previous 9,516 13.13%

Holding current value

$27,127

Previous $19,000 5.26%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.23 - $2.25 $1,536 - $2,810	1,249 Added 13.13%	10,765 $20,000
Q2 2024 Aug 08, 2024	BUY	$2.0 - $4.45 $126 - $280	63 Added 0.67%	9,516 $19,000
Q1 2024 May 08, 2024	BUY	$2.16 - $5.94 $18,522 - $50,935	8,575 Added 976.65%	9,453 $42,000
Q3 2023 Nov 13, 2023	SELL	$1.06 - $3.91 $104,819 - $386,644	-98,886 Reduced 99.12%	878 $1,000
Q2 2023 Aug 10, 2023	BUY	$3.08 - $9.55 $250,610 - $777,054	81,367 Added 442.28%	99,764 $328,000
Q1 2023 May 09, 2023	SELL	$4.0 - $7.02 $20,048 - $35,184	-5,012 Reduced 21.41%	18,397 $75,000
Q4 2022 Feb 08, 2023	BUY	$5.65 - $7.86 $11,339 - $15,775	2,007 Added 9.38%	23,409 $137,000
Q3 2022 Nov 04, 2022	BUY	$4.63 - $8.0 $78,330 - $135,344	16,918 Added 377.3%	21,402 $144,000
Q2 2022 Jul 29, 2022	SELL	$2.84 - $5.0 $147,606 - $259,870	-51,974 Reduced 92.06%	4,484 $20,000
Q1 2022 May 05, 2022	BUY	$3.74 - $6.63 $211,152 - $374,316	56,458 New	56,458 $224,000
Q1 2021 May 10, 2021	SELL	$15.31 - $26.52 $102,423 - $177,418	-6,690 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$16.84 - $27.59 $181,787 - $297,834	-10,795 Reduced 61.74%	6,690 $177,000
Q3 2020 Nov 09, 2020	SELL	$16.2 - $25.7 $554,266 - $879,299	-34,214 Reduced 66.18%	17,485 $325,000
Q2 2020 Aug 05, 2020	SELL	$5.24 - $23.4 $212,340 - $948,238	-40,523 Reduced 43.94%	51,699 $1.2 Million
Q1 2020 May 06, 2020	BUY	$4.41 - $9.28 $406,699 - $855,820	92,222 New	92,222 $541,000
Q4 2019 Jan 29, 2020	SELL	$1.45 - $6.73 $26,200 - $121,604	-18,069 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$1.54 - $4.2 $6,420 - $17,509	4,169 Added 29.99%	18,069 $28,000
Q2 2019 Aug 09, 2019	BUY	$3.84 - $6.4 $15,744 - $26,240	4,100 Added 41.84%	13,900 $56,000
Q1 2019 May 13, 2019	BUY	$3.51 - $7.3 $34,398 - $71,540	9,800 New	9,800 $51,000
Q3 2018 Oct 26, 2018	SELL	$10.0 - $19.02 $428,580 - $815,159	-42,858 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$13.56 - $18.48 $581,154 - $792,015	42,858 New	42,858 $676,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

74K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $245M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Mersana Therapeutics, Inc. Transaction History